Matt’s Act

Summary

Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge an uninsured individual who has diabetes the average net price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 22 July 2020

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 22 July 2020

   Introduced

   Introduced in House

   Source: IntroReferral

3. 22 July 2020

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 22 July 2020 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 22 July 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 22 July 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 22 July 2020

  Open at official source

Sponsors

• Jeff Fortenberry · R · Sponsor
• Angie Craig · D · Sponsor
• · hsed00 · Standing
• · hsif00 · Standing

Related records

• related to → Matt’s Act